[New therapeutic trends in Mendelson's syndrome. Description of a clinical case].
D000328:Adult; D007611:Aprotinin / Q000627:therapeutic use; D001463:Barbiturates / Q000506:poisoning; D003128:Coma / Q000628:therapy; D003566:Cytidine Diphosphate Choline / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007385:Intermittent Positive-Pressure Ventilation; D007610:Kallikreins / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D011015:Pneumonia, Aspiration / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D011663:Pulmonary Surfactants / Q000096:biosynthesis*; D012436:S-Adenosylmethionine / Q000627:therapeutic use; D013268:Stimulation, Chemical
D001463:Barbiturates; D011663:Pulmonary Surfactants; D003566:Cytidine Diphosphate Choline; D012436:S-Adenosylmethionine; D007611:Aprotinin; D007610:Kallikreins; D006854:Hydrocortisone
Nuovi orientamenti terapeutici nella sindrome di Mendelson. Descrizione di un caso clinico.